Q5118
HCPCSInj., zirabev, 10 mg
Official HCPCS Level II long descriptor
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
HCPCS Level II code Q5118 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj., zirabev, 10 mg
Added to HCPCS: 2019-10-01
Nearby codes in Q5
- Q5110Nivestym
- Q5111Injection, udenyca 0.5 mg
- Q5112Inj ontruzant 10 mg
- Q5113Inj herzuma 10 mg
- Q5114Inj ogivri 10 mg
- Q5115Inj truxima 10 mg
- Q5116Inj., trazimera, 10 mg
- Q5117Inj., kanjinti, 10 mg
- Q5119Inj ruxience, 10 mg
- Q5120Inj pegfilgrastim-bmez 0.5mg
- Q5121Inj. avsola, 10 mg
- Q5122Inj, nyvepria
- Q5123Inj. riabni, 10 mg
- Q5124Inj. byooviz, 0.1 mg
- Q5125Inj, releuko 1 mcg
- Q5126Inj alymsys 10 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.